Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study
Mohammed M. Alanazi, Hazem Elkady, Nawaf A. Alsaif, Ahmad J. Obaidullah, Wael A. Alanazi, Abdulah M. Al-Hossaini, Madhawi A. Alharbi, Ibrahim H. Eissa, Mohammed A. Dahab
Topics & Concepts
ChemistryQuinoxalineIn silicoDocking (animal)Combinatorial chemistryIC50SorafenibStereochemistryComputational biologyIn vitroMolecular modelDrug discoveryAnticancer drugBiochemistryDrugPharmacologyCancer researchOrganic chemistryMedicineGeneBiologyNursingHepatocellular carcinomaSynthesis and Biological EvaluationBioactive Compounds and Antitumor AgentsSynthesis and biological activity